IL123383A0 - Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of P53-related tumors - Google Patents
Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of P53-related tumorsInfo
- Publication number
- IL123383A0 IL123383A0 IL12338396A IL12338396A IL123383A0 IL 123383 A0 IL123383 A0 IL 123383A0 IL 12338396 A IL12338396 A IL 12338396A IL 12338396 A IL12338396 A IL 12338396A IL 123383 A0 IL123383 A0 IL 123383A0
- Authority
- IL
- Israel
- Prior art keywords
- igf
- insulin
- treatment
- growth factor
- binding protein
- Prior art date
Links
- 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 title 2
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US373095P | 1995-09-14 | 1995-09-14 | |
PCT/US1996/014623 WO1997009998A2 (en) | 1995-09-14 | 1996-09-12 | Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL123383A0 true IL123383A0 (en) | 1998-09-24 |
Family
ID=21707302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12338396A IL123383A0 (en) | 1995-09-14 | 1996-09-12 | Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of P53-related tumors |
Country Status (8)
Country | Link |
---|---|
US (1) | US5840673A (en) |
EP (1) | EP0871475A2 (en) |
JP (1) | JP2000502322A (en) |
AU (1) | AU718451B2 (en) |
CA (1) | CA2232000A1 (en) |
IL (1) | IL123383A0 (en) |
NO (1) | NO981127L (en) |
WO (1) | WO1997009998A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020135A (en) * | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
CA2370003C (en) | 1999-01-13 | 2008-08-19 | Tracey Brown | A composition and method for the enhancement of the efficacy of drugs |
WO2000050067A1 (en) * | 1999-02-26 | 2000-08-31 | Saltech I Göteborg Ab | Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1 |
AU2001264769A1 (en) * | 2000-05-17 | 2001-11-26 | Oregon Health And Sciences University | Induction of apoptosis and cell growth inhibition by protein 4.33 |
AUPQ879500A0 (en) * | 2000-07-14 | 2000-08-10 | Meditech Research Limited | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease |
US9066919B2 (en) * | 2000-07-14 | 2015-06-30 | Alchemia Oncology Pty Limited | Hyaluronan as a chemo-sensitizer in the treatment of cancer |
US20030035788A1 (en) * | 2000-09-19 | 2003-02-20 | Desmond Mascarenhas | Method for use of IGF-binding protein for selective sensitization of target cells in vivo |
CA2458856C (en) * | 2001-08-27 | 2011-02-15 | Meditech Research Limited | Improved therapeutic protocols |
US6914049B2 (en) | 2001-09-18 | 2005-07-05 | Bioexpertise, Llc | IGF-binding protein-derived peptide or small molecule |
US6887851B2 (en) * | 2001-09-18 | 2005-05-03 | Bioexpertise, Llc | IGF-binding protein-derived peptide |
EP1435986B1 (en) * | 2001-09-18 | 2008-01-02 | Bioexpertise, Llc | Igf-binding protein-derived peptide |
US7166288B2 (en) * | 2002-02-13 | 2007-01-23 | The Trustees Of Columbia University In The City Of New York | Use of insulin-like growth factor binding protein 3 (IGF-BP3) for inhibition of tumor growth |
US20040005294A1 (en) * | 2002-02-25 | 2004-01-08 | Ho-Young Lee | IGFBP-3 in the diagnosis and treatment of cancer |
WO2004111262A1 (en) * | 2003-06-18 | 2004-12-23 | Pharmacia & Upjohn Company Llc | Method of identifying a selective chemotherapeutic agent |
WO2005033132A2 (en) * | 2003-10-03 | 2005-04-14 | Genentech, Inc. | Igf binding proteins |
WO2006017824A2 (en) * | 2004-08-06 | 2006-02-16 | The Trustees Of Columbia University In The City Of New York | Igf-bp3-related methods for inhibiting tumor growth |
US7699677B2 (en) * | 2004-12-28 | 2010-04-20 | Independent Administrative Institution, Japan Agency For Marine-Earth Science And Technology | Profiling float and usage of the profiling float |
CA2616607C (en) * | 2005-07-27 | 2015-06-02 | Alchemia Oncology Pty Limited | Therapeutic protocols using hyaluronan |
JP5627181B2 (en) * | 2005-09-07 | 2014-11-19 | アルケミア オンコロジー ピーティーワイ リミテッド | Therapeutic compositions comprising hyaluronan and therapeutic antibodies and methods of treatment |
US20100316639A1 (en) | 2009-06-16 | 2010-12-16 | Genentech, Inc. | Biomarkers for igf-1r inhibitor therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004030A1 (en) * | 1992-08-26 | 1994-03-03 | Celtrix Pharmaceuticals, Inc. | Method for systemic treatment of catabolic conditions and systemic tissue injury |
US5573925A (en) * | 1994-11-28 | 1996-11-12 | The Wistar Institute Of Anatomy And Biology | P53 proteins with altered tetramerization domains |
-
1996
- 1996-09-12 AU AU69752/96A patent/AU718451B2/en not_active Ceased
- 1996-09-12 WO PCT/US1996/014623 patent/WO1997009998A2/en not_active Application Discontinuation
- 1996-09-12 JP JP9512100A patent/JP2000502322A/en active Pending
- 1996-09-12 US US08/713,052 patent/US5840673A/en not_active Expired - Lifetime
- 1996-09-12 IL IL12338396A patent/IL123383A0/en unknown
- 1996-09-12 CA CA002232000A patent/CA2232000A1/en not_active Abandoned
- 1996-09-12 EP EP96930842A patent/EP0871475A2/en not_active Ceased
-
1998
- 1998-03-13 NO NO981127A patent/NO981127L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU6975296A (en) | 1997-04-01 |
EP0871475A2 (en) | 1998-10-21 |
NO981127D0 (en) | 1998-03-13 |
MX9801704A (en) | 1998-05-31 |
US5840673A (en) | 1998-11-24 |
CA2232000A1 (en) | 1997-03-20 |
JP2000502322A (en) | 2000-02-29 |
NO981127L (en) | 1998-03-13 |
WO1997009998A3 (en) | 1997-04-10 |
WO1997009998A2 (en) | 1997-03-20 |
AU718451B2 (en) | 2000-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL123383A0 (en) | Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of P53-related tumors | |
EP0785276A4 (en) | Modification of peptide and protein | |
HUP9601120A3 (en) | Recombinant obese (ob) proteins | |
GB9225453D0 (en) | Binding proteins | |
AU4230196A (en) | Treatment of pancreatic tumors with peptide yy and analogs thereof | |
ZA969444B (en) | Peptides which enhance transport across tissues and methods of identifying and using the same | |
AU5283793A (en) | Recombinant specific binding protein | |
EP0742793A4 (en) | Bcl-2-associated proteins | |
AU1116297A (en) | Flk-1 binding protein | |
AU3118897A (en) | Immunoassay of total insulin-like growth factor binding protein-1 | |
IL106278A0 (en) | Bone formation-inducing protein | |
AU5716696A (en) | Decorin binding protein compositions and methods of use | |
ZA955430B (en) | Tumor necrosis factor receptor-ii associated protein kinase and method for their use | |
EP0750848A4 (en) | Modifier and modifier composition for protein-containing substance | |
AU3120195A (en) | Small cell lung carcinoma peptides and binding agents | |
AU5446694A (en) | Process for enhancing the content of a selected amino acid in a seed storage protein | |
IL114417A0 (en) | Tumor necrosis factor receptor-I associated proteins and protein kinase and methods for their use | |
AU2186895A (en) | Polypeptides of lipopolysaccharide binding protein | |
AU1888692A (en) | Composition and method for treating tumors | |
EP0546081A4 (en) | New insulin-like growth factor binding protein (igfbp-4) | |
ZA963530B (en) | Recombinant obese (ob) proteins | |
HUP9900011A3 (en) | Use of protein gax for treating cancer | |
AU3942097A (en) | Amino acid composition and use thereof in treating tumor growth and metastasis | |
AU4687997A (en) | In vivo protein synthesis method | |
IL128444A0 (en) | Conjugated peptides immunological reagent containing same and use thereof for treatment of immunological disorders |